2019 Healthcare Professional Provider Supply Chain 
FDA Law Blog
FEBRUARY 16, 2023
sales of naloxone from a wholesale distributor to a harm reduction program) from certain requirements under the Drug Supply Chain Security Act. We previously blogged on FDA’s September 2022 guidance exempting and excluding specific naloxone transactions (e.g.,
BMJ
AUGUST 20, 2021
In the United Kingdom (UK), primary care practitioners are the first-line clinicians which most patients encounter, providing initial assessment and treatment of a wide variety of conditions. Over one billion prescriptions per year are signed in the UK by these general practitioners (GPs) in primary care.
Expert insights. Personalized for you.
64 
Let's personalize your content